STOP C

The SToP-C project demonstrated that scale-up of direct-acting antiviral (DAA) treatments in the prison setting can successfully reduce the incidence of transmissions, make an important contribution to national efforts to achieve hepatitis C elimination as an ongoing public health threat, and also provide improved health outcomes for the individuals receiving curative treatment. This toolkit describes the steps necessary to achieve those outcomes... A guide to the scale-up of antiviral treatment for hepatitis C in the prisons | Together we can reduce the spread of hepatitis C in the prisons

Primary location: Kensington